Amisulpride (Barhemsys) PONV

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org. 

2 posts / 0 new
Log in or register to post comments
Last post
Mon, 05/24/2021 - 17:00
#1
Asmaa Debri
Asmaa Debri's picture
Offline
Last seen: 3 months 3 weeks ago
Joined: 04/08/2020 - 11:26
Amisulpride (Barhemsys) PONV

We recently had a request to review and add amisulpride to our formulary by an anesthesiologist. This is a newer medication with a unique mechanism of action in the postoperative nausea/vomiting world. Curious to hear what other health systems are doing:
1) Are your anesthesiologists asking for this medication to be added to formulary?
2) If your System P&T reviewed this medication:
a.What is the formulary designation?
b.Which electronic health record platform are you using?
i.Did you add this medication to any prebuilt orders for pre-op or post-op settings?

Top